Home Global Health Policy Topics

new and noteworthy

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2025

This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2025, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials

Global Health Trackers

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

Latest News

More KFF Health News

Stay informed.

Get KFF's latest on Global Health Policy

Stay informed.

Get KFF's latest on Global Health Policy

View the Latest: Global Health Policy

Filter

List Grid

631-640 of 659 results

  • Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Rose to US$8.1 Billion in 2017 due to Shift in Timing of U.S. Support

    News Release

    Donor government disbursements to combat HIV in low- and middle-income countries increased 16 percent from US$7 billion in 2016 to US$8.1 billion in 2017 – though the higher total stems largely from the timing of U.S. funding and is not expected to last, a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) finds. The increase follows two years of declines in donor support for HIV and results largely…

  • August 10 Event – AIDS 2018: What Happened and What’s Next?

    Event Date:
    Event

    On Friday, August 10, the Kaiser Family Foundation and the Global Health Policy Center at the Center for Strategic and International Studies (CSIS) held a briefing to assess the major outcomes of the 2018 International AIDS Conference (AIDS 2018), held from July 23-27 in Amsterdam, the Netherlands. The discussion touched on the latest scientific developments; the current funding climate for the AIDS response; and other major developments to the field emerging from the conference. In…

  • The Latest Ebola Outbreak: What’s Different about the U.S. and International Response?

    News Release

    The United States played a leading role in the international response to the 2014 Ebola outbreak in West Africa, providing the most financial support, mobilizing U.S. staff across the federal government, and jumpstarting international efforts to strengthen global health security. As this month’s new outbreak unfolds in the Democratic Republic of Congo (DRC), the U.S. so far is playing a more limited role. A new Kaiser Family Foundation brief examines key differences and changes since…

  • The U.S. Government and Global Health Security

    Issue Brief

    This brief examines the U.S. government's efforts in global health security—that is, activities to help countries prepare for and develop capacities to address epidemic and pandemic diseases. It provides history and background, outlines the U.S. agencies carrying out these efforts, describes funding, and highlights key policy issues going forward.

  • Donor Government Funding for Family Planning in 2016

    Report

    A new Kaiser Family Foundation report finds that donor government funding for family planning declined in 2016 for the second year in a row, decreasing to US$1.19 billion compared to US$1.34 billion in 2015. While the declines over this two-year period were largely due to exchange rate fluctuations and the timing of donor disbursements which accounted for 78 percent of the overall decrease, there were actual cuts in funding from some donor countries which accounted…

  • The ‘Pandemic Agreement’: What it is, What it isn’t, and What it Could Mean for the U.S.

    Issue Brief

    Countries are seeking to create a new 'pandemic agreement' at WHO to strengthen pandemic prevention, preparedness, and response. This brief explains what the pandemic agreement is, where the U.S. stands on issues included in the agreement, and potential outcomes of the ongoing negotiations. It also evaluates several criticisms of the agreement and the evidence for each.

  • The International Health Regulations and the U.S.: Implications of an Amended Agreement

    Issue Brief

    This brief reviews the proposed revisions to the World Health Organization-based agreement known as the International Health Regulations (IHR), and the implications for the U.S. WHO member states are expected to adopt the revised IHR at the World Health Assembly meeting this year. The U.S. government has been a leading proponent of many of the expected revisions to the IHR. In this analysis we also evaluate some of the criticisms of the revisions to the…

  • Impact of the Mexico City Policy: Literature Review

    Issue Brief

    This literature review identifies studies examining the impact of the Mexico City Policy, from 2001 to the present, with particular focus on capturing recent studies assessing the policy under the Trump administration.

  • The Efficacy of a New Long-Acting Injectable PrEP

    Quick Insights

    The news today about the efficacy of a new long-acting injectable PrEP, the second such breakthrough announcement in recent months, is nothing short of groundbreaking.